Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;39(5):434-40.
doi: 10.1111/1753-6405.12451.

Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy

Affiliations

Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy

Susan J Jordan et al. Aust N Z J Public Health. 2015 Oct.

Abstract

Objectives: To estimate the proportion and number of cancers occurring in Australia in 2010 attributable to menopausal hormone therapy (MHT) use.

Methods: We estimated the population attributable fraction for cancers causally associated with MHT (breast, endometrium, ovary), and the proportion of colorectal cancers prevented by MHT. We used standard formulae incorporating Australian prevalence data, relative risks of cancer associated with MHT and cancer incidence. We also estimated potential change in cancer incidence under two hypothetical scenarios whereby 25% fewer Australian women used MHT, or women exclusively used oestrogen-only MHT.

Results: An estimated 539 cancers in Australia in 2010 were attributable to MHT: 453 breast, 67 endometrial and 19 ovarian cancers equating to 3.4%, 3.1% and 1.6% of each cancer type, respectively. In contrast, MHT may have prevented 52 colorectal cancers. If 25% fewer women used MHT, then 141 cancers may have been avoided. If women exclusively used oestrogen-only MHT then 240 cancers may have been avoided.

Conclusions: MHT use caused more than 500 cancers in Australian women in 2010 and prevented ∼50 colorectal cancers.

Implications: MHT use continues to cause an excess of cancers. The risks, benefits, regimen and treatment duration should be carefully considered for each woman before MHT is commenced.

Keywords: cancer; menopausal hormone therapy; population attributable fraction; potential impact fraction; risk factor.

PubMed Disclaimer

References

    1. Australasian Menopause Society. Australasian Menopause Society New Directions in Womens Health Information Sheet: Glossary of Terms [Internet] Melbourne (AUST): AMS; 2009. [cited 2014 Apr 6]. Available from: http://www.menopause.org.au/images/stories/infosheets/docs/glossary_of_t....
    1. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. C-Gyn 16 Hormone Replacement Therapy Advice [Internet] Melbourne (AUST): RANZCOG; 2012. [cited 2014 Apr 6]. Available from: http://www.ranzcog.edu.au/doc/hormone-replacement-therapy-advice.html.
    1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33. - PubMed
    1. Canfell K, Banks E, Moa AM, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust. 2008;188(11):641–4. - PubMed
    1. Australian Bureau of Statistics. 2004-2005 National Health Survey Expanded CURF, RADL. Findings Based on Use of ABS CURF Data. Canberra (AUST): ABS; 2005.

Publication types

MeSH terms